The blood clotting cascade is selectively involved in lung metastasis, but the reason for this selectivity is unclear. Here we show that tumor cells that metastasize predominantly to the lung, such as renal cell carcinoma (RCC) and soft tissue sarcoma (STS), have an inherent capacity to generate extensive invadopodia when embedded in a blood clot.
INTRODUCTION
Metastasis to distant organs is a common complication of malignant tumors (1) . While organ confined primary tumors can be cured by surgical excision, the overwhelming majority of patients with metastases has an extremely poor prognosis. Resection of solitary metastases, immune therapy as well as treatment with targeted drugs designed to block growth and survival pathways has had some success, but after a phase of remission, patients typically suffer disease recurrence and progression (2, 3) . These outcomes warrant further mechanistic studies towards the identification of novel targets for more efficient anti-metastatic treatments.
The metastatic cascade begins at the site of the primary tumor from where tumor cells are shed into the blood circulation (1) . After entering the blood stream, tumor cells attach in the vasculature of distant organs and extravasate into the perivascular tissue, where they either begin to proliferate and form metastases or become dormant. While the initial tumor cell attachment does not require clotting activity, thrombus formation becomes relevant in the subsequent steps of metastatic seeding by promoting invasive functions that enable tumor cell extravasation and by protecting tumor cells from circulating immune cells (4, 5) . Moreover, it has been shown that blood clot provides a microenvironment that is crucial for maintenance and proliferation of tumor initiating cells (6) . Conversely, inhibiting clotting with anti-coagulants or knocking down critical coagulation and platelet factors in transgenic mice (e.g. tissue factor, fibrinogen, GĮq) has a marked anti-metastatic effect, indicating that the generation of a fibrin platelet thrombus plays a key role for metastasis (7, 8) .
In addition to host factors, the capacity of tumor cells to metastasize requires a specific set of tumor cell functions including the ability to invade as a single cell (9) . These specific pro-migratory and pro-invasive functions are induced by transcriptional programs that mediate epithelial-mesenchymal transition (EMT) in tumor cells (9) . EMT is regulated by a set of zinc finger (snail, slug, Zeb1/2) and bHLH transcription factors (Twist, Foxc2), which cause down-regulation of epithelial markers, most notably Ecadherin, and up-regulation of mesenchymal markers such as vimentin, N-cadherin, fibronectin and integrins (10) . EMT can be initiated by oncogenes, hypoxia as well as a number of soluble factors including TGF-ȕ and Wnt (11) (12) (13) (14) . In addition, it has been shown that integrins typically upregulated in cancer such as Įvȕ3 can promote EMT through degradation of E-cadherin and activation of intracellular signaling cascades (15) .
Integrin Įvȕ3 has been detected in tumor tissues from patients with melanoma, breast, and pancreatic cancer and its expression is particularly pronounced in metastatic tissue (16) (17) (18) . Tumor cells that express integrin Įvȕ3 metastasize aggressively and blocking integrin Įvȕ3 with antibodies, RGD-containing peptides or siRNA inhibits this process (5, 16, 19) . Metastasis mediated through Įvȕ3 has been shown to depend on integrin activation, suggesting that Įvȕ3 function is controlled on the transcriptional as well as post translational level (20) . Using plasma fibronectin-deficient mice, we previously showed that Įvȕ3-mediated lung metastasis depends on fibrin-fibronectin complexes, which facilitate invadopodia formation in clot-embedded tumor cells by activating integrin Įvȕ3 (5). To determine if there is a correlation between lung metastasis and clot invasion, we assessed the capacity of human tumor cells to generate invadopodia in clotted plasma and tested if invadopodia formation in clotted plasma is governed by mechanisms relevant for lung metastasis.
MATERIALS AND METHODS
Tumor Cells. RCC4, 786-0, CAKI-1 (renal cell carcinoma, RCC), HT1080, RD (soft tissue sarcoma, STS), U87MG (glioblastoma), MDA-MB-231, MCF-7 (breast cancer), A375 (melanoma), PANC1 (pancreatic cancer), PC-3 and LNCaP (prostate cancer) cell lines were purchased from ATCC and cultured per manufacturer's specifications for less than 6 months. Primary human tumor cells were isolated from patients with metastatic and localized RCC (Supplementary Table 1) . Immediately following resection, tumors were inspected by an anatomical pathologist and harvested under sterile conditions, then de-identified by the tissue bank of the University of Pittsburgh Cancer Institute.
Upon receipt in the laboratory, the tissue was cut into small pieces, washed once with sterile PBS and digested with 2.4 U/ml dispase II (Roche) at 37°C for 50 minutes on a rotator. The suspension was centrifuged at 1100 rpm for 5 min at 4°C and the pellet was resuspended in DMEM media containing 10% FBS. Cells were cultured at 37°C under a humidified, 5% CO 2 atmosphere before cryopreservation. MDA-MB-231 or A375 cells (Invitrogen) and perfused through the heart after 1 hour.
Lung tissue was snap frozen in OCT after isolation. Frozen tissues were sectioned, fixed with acetone and stained with biotinylated mouse fibrin(ogen) antiserum (Nordic), followed by streptavidin Alexa Fluor 594 (Invitrogen). Nuclei were stained with DAPIcontaining mounting media (Vectashield). Tissues were analyzed at 20x magnification using a fluorescence microscope (Zeiss Axioplan 2) and scored for co-localization of tumor cells with fibrin.
Three-Dimensional Cell Culture. Clot embedding was performed as previously described (5 Western blot analysis. Cell pellets were lysed by adding 2x SDS sample buffer.
Proteins were separated by SDS-PAGE, transferred onto PVDF and stained with 0.05% Ponceau S (Sigma) to ensure equivalent protein loading. Immunoblots were blocked with 5% bovine serum albumin and probed overnight at 4°C with antibodies against integrin ȕ3 (BD Biosciences), fibronectin (EMD Millipore), vimentin, E-cadherin, Ncadherin, twist, snail and slug (Cell Signaling Technology). Immunoreactivity was detected using peroxidase-conjugated anti-rabbit or anti-mouse IgG antibody and visualized by enhanced chemiluminescence.
Cell Adhesion Assay. Cell adhesion was measured as previously described (21). Fig. 2A-B) . This is in stark contrast to the phenotype of a random panel of breast, prostate, melanoma and pancreatic tumor cell lines that displayed a ratio of spread, invadopodia-positive cells to round, invadopodia-negative cells of less than 10% ( Fig. 2A-B adhesive mechanisms guiding invadopodia formation, we embedded the clot-invasive tumor cell lines in fibrin or matrigel. Interestingly, while these cells maintained their capacity to generate invadopodia in fibrin, which is the main component of clotted plasma, most of them showed only limited ability to spread in matrigel (Fig. 2C) , suggesting that clot invasion is mediated by a specific set of adhesive cell functions that facilitate interaction with fibrin. Together, our results indicate that our panel of RCC, STS and glioblastoma cells represents a specific fibrin-interactive phenotype that promotes invadopodia formation in a 3-dimensional matrix of clotted plasma. integrins had no such effects (Fig. 4A, Supplementary Fig. S2A-B) . In addition, we saw a significant negative effect of ȕ3 siRNA/shRNA on tumor cell proliferation and colony formation (Fig. 4A, Supplementary Fig. S2C-D) . Transient knockdown of Įvȕ3 in HT1080 cells with siRNA was also sufficient to reduce experimental lung metastasis, 
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suggesting that integrin Įvȕ3-mediated functions are necessary in the initial phase of lung colonization, when clotting plays an important role for the tumor cell fate (Fig. 4B) .
To further assess the role of integrin Įvȕ3 for invadopodia formation, we labeled our tumor cell panel with wow1 antibody, which binds only activated integrin Įvȕ3 (22) .
Using flow cytometry, we detected wow1-binding as an indicator of Įvȕ3 activation on each of the invadopodia-positive tumor cells but only on one out of 4 invadopodianegative tumor cell lines (Fig. 4C-D) . The functional difference of Įvȕ3 was also detectable when we tested cell attachment to the fibrin-precursor fibrinogen, a plasma adhesion protein that specifically interacts with activated Įvȕ3 but not with the resting integrin (21) . This experiment showed that invadopodia-positive tumor cells spontaneously adhere and spread on fibrinogen while most of the invadopodia-negative tumor cells are unable to attach unless manganese was added for Įvȕ3 activation (Fig.   4E-F, Supplementary Figure S3 ). An exception from this pattern is represented by the invadopodia-negative A375 cells, which bound wow1 and adhered spontaneously but were unable to spread on fibrinogen (Fig. 4D-E, Supplementary Figure S3) . Together, these results indicate that expression of activated integrin Įvȕ3 on tumor cells is a prerequisite for invadopodia formation and lung metastasis.
Integrin Įvȕ3 promotes fibronectin matrix formation in invadopodia-forming tumor cells. Fibronectin matrix formation has been shown to depend on integrin activation (24) . In line with this, we found that fibrin embedded 786-0 and HT1080 cells, which both express activated Įvȕ3, generated an elaborate fibronectin matrix while MDA-MB-231 cells, which only expressed inactive Įvȕ3 were unable to do so (Fig. 5A CAN-13-0602 C). Moreover, fibronectin matrix formation was strongly reduced in 786-0 cells transfected with siRNA against ȕ3 integrin compared to transfection with integrin ȕ1 siRNA, indicating that Įvȕ3 plays a pivotal role in organizing the extracellular matrix in clot-embedded cells (Fig. 5A, C) . To further delineate the interaction between fibronectin and integrin Įvȕ3 in fibrin-embedded tumor cells, we analyzed F-actin dynamics in 786-0 cells fluorescently labeled with phalloidin (Fig. 5B, D) . Using confocal microscopy, we identified extensive stress fibers that were associated with a wellorganized meshwork of fibronectin fibrils in control-transfected cells. The ability to generate stress fibers remained intact in cells transfected with integrin ȕ1 siRNA but was markedly impaired when we knocked down fibronectin or integrin Įvȕ3. These results suggest a prominent role of integrin Įvȕ3 and fibronectin for spreading in fibrin.
In support of this concept, our results show that inhibiting fibronectin expression with siRNA or shRNA impairs invadopodia formation and proliferation of fibrin-embedded 786-0 and HT1080 cells in a manner similar to inhibiting integrin Įvȕ3 ( Fig. 5E; Supplementary Figure S4) . In contrast to knocking down Įvȕ3, which strongly diminished tumor cell adhesion to fibrinogen, treatment with fibronectin siRNA had no effect on this function indicating that fibronectin supports invadopodia formation downstream of the pathways that govern integrin Įvȕ3 activation (Fig. 5F) . Together, our results show that integrin Įvȕ3 supports fibronectin matrix formation and that this interaction is critical for spreading and proliferation of fibrin-embedded tumor cells. To follow up on these findings, we analyzed primary kidney tumor cells from patients with metastatic and non-metastatic disease for ȕ3, fibronectin and slug expression ( Table 1) . While we found Įvȕ3 expressed in metastatic as well as non-metastatic cells, we saw a striking difference with respect to invadopodia formation, fibronectin expression and fibronectin matrix formation, which all were extensive among the metastatic RCC cells but barely detectable in non-metastatic RCCs (Fig. 7A-D) .
While cells from metastatic tumor #3 invaded to a lesser extent compared to the metastatic cell lines #1 and #2, these cells also expressed lower levels of slug than the other metastatic cell lines. Paralleling these results, we found that cell lines #1 and #2 are derived from patients with lung metastasis whereas patient #3 suffered from 
DISCUSSION
We previously showed that clot formation promotes lung metastasis but not metastasis to the liver (5). Here we demonstrate that tumor cells from cancers that predominantly metastasize to lungs, such as RCC and STS (25, 26) , generate extensive invadopodia in clotted plasma and fibrin. Invadopodia formation in these cells is mediated by activated integrin Įvȕ3, fibronectin and slug, which in turn promotes experimental lung metastasis in vivo. The correlation between slug expression, fibronectin matrix formation and fibrin invasion was confirmed in primary tumor cells recently isolated from patients with metastatic RCC suggesting that our finding is clinically relevant.
Extravasation of tumor cells from the blood circulation to the interstitial spaces of a target organ is thought to be a critical step of the metastatic cascade (1). In the liver or the bone marrow, this process is facilitated by capillaries that are decorated with discontinuous, fenestrated endothelium (27) . However, tumor cell extravasation in the lung is more demanding because of the lung vasculature's tight endothelial junctions that are in place to prevent fluid leakage and cell passage into the alveolar compartment 
upregulation of EMT markers and transcription factors in line with previous reports that these cell lines are in fact considered to be invasive. One of the major differences between non-clot invasive and clot invasive tumor cells, however, is the expression of activated integrin Įvȕ3, which we found is a prerequisite for adhesion to fibrinogen and invadopodia formation in fibrin. Most invadopodia-negative tumor cells, in contrast, express an inactive form of integrin Įvȕ3, which correlates with their inability to induce the shape change that is necessary for penetrating a fibrin barrier or navigating narrow inter-endothelial spaces in the pulmonary vasculature (29) .
The pro-invasive function of integrin Įvȕ3 in fibrin-embedded tumor cells is connected to fibronectin, which is significantly expressed in RCC and STS. Fibronectin has been shown to be overexpressed in metastatic tumor cells and tissues, where it promotes invasion, proliferation and survival through RGD-dependent interaction with integrin (36, 37) . Expressed on circulating tumor cells, fibronectin represents a marker for disease progression and treatment resistance (38) . While tumor cells grown on 2-dimensional cell culture plastic rarely generate a fibronectin matrix (39), we detected extensive fibronectin matrix assembly around fibrin-embedded RCC and STS cells. Fibronectin matrix formation was strongest in tumor cells from metastatic cancer whereas cells from localized cancer barely expressed fibronectin at all. This is in line with previous findings that breast tumor cells grown in a 3-dimensional environment require fibronectin matrix assembly and stress fiber formation for cell cycle progression in vitro and metastatic outgrowth in vivo (40) . However, while fibronectin-dependent outgrowth of breast cancer cells depends on interactions of fibronectin with ȕ1 integrin, we show here that in fibrin- 
embedded RCC and STS cells, invadopodia formation, fibronectin matrix assembly and stress fiber formation is uniquely controlled by integrin Įvȕ3.
In addition to the capacity to assemble a fibronectin matrix, invadopodia formation correlates closely with the expression of the EMT transcription factor slug, which also mediated experimental metastasis to the lungs. Slug has been shown to promote invasion and metastasis in a number of cancers and its expression in clinical tumor tissues is frequently associated with poor outcome (13, 41, 42) . Specifically, slug expression has been shown to be enhanced in metastatic RCC and this correlates with a decrease in progression-free survival (43, 44) . Slug expression is commonly induced by TGF-ȕ or Wnt signaling, both of which represent important EMT pathways (13, 14) .
However, while we detected robust smad2 phosphorylation in RCC and STS cells, we did not find any connection between TGF-ȕ and slug. Instead, we identified a positive relationship between integrin Įvȕ3, fibronectin and slug expression indicating that clot invasion in RCC and STS cells is directly controlled by adhesive interactions with the extracellular matrix. This mechanism leads to stress fiber formation, which has been shown to be a prerequisite for the maturation of focal adhesions (45) . Importantly, actinmyosin mediated cellular tension and subsequent focal adhesion formation leads to stabilization and nuclear translocation of ȕ-catenin, a transcription factor critical for slug expression (46, 47) . Moreover, it has been shown that slug can be induced by the GTPase RhoA, which mediates stress fiber formation in cooperation with integrins and fibronectin (14, 48, 49) . Intriguingly, this mechanism could also explain colony formation analyzed for fibronectin matrix formation (green) using confocal microscopy. Nuclei are stained with draq5 (blue). Scale bar, 50 μm.
